These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1654494)

  • 1. [The transmission of maternal measles antibodies to newborn infants in the Ivory Coast].
    Rey JL; Lhuillier M; Dem M; Soro B; Saki Z; Davis CE
    Med Trop (Mars); 1991; 51(2):215-8. PubMed ID: 1654494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decay of maternally derived measles antibody in central Turkey.
    Metintaş S; Akgün Y; Arslantaş D; Kalyoncu C; Uçar B
    Public Health; 2002 Jan; 116(1):50-4. PubMed ID: 11896637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Loss of maternal measles antibodies acquired by vaccination against measles].
    Strauss J; Mrázová M; Macátová I; Beranová I
    Cesk Epidemiol Mikrobiol Imunol; 1991 May; 40(3):137-43. PubMed ID: 1828716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles antibodies in the breast milk of nursing mothers.
    Adu FD; Adeniji JA
    Afr J Med Med Sci; 1995 Dec; 24(4):385-8. PubMed ID: 8886155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measles and mumps antibody concentrations in newborns and their mothers--follow up first year of life].
    Hohendahl J; Peters N; Hüttermann U; Rieger C
    Klin Padiatr; 2006; 218(4):213-20. PubMed ID: 16819702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers.
    Szenborn L; Tischer A; Pejcz J; Rudkowski Z; Wójcik M
    Med Sci Monit; 2003 Dec; 9(12):CR541-6. PubMed ID: 14646978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
    Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
    Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of maternal antibodies against measles (is the policy of vaccinating children younger than nine months of age suitable for Turkey?).
    Kanra G; Ceyhan M
    Turk J Pediatr; 1991; 33(4):217-20. PubMed ID: 1814038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Age-related loss of maternal antibodies against measles in children in La Plata].
    del Buono MB; Vaschetti P; Iannicelli J; Silber R
    Rev Argent Microbiol; 2003; 35(2):102-5. PubMed ID: 12920993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of placentally transmitted antibodies for measles in infants 3 to 11 months old in an urban slum community.
    Deivanayagam N; Vasudevan S; Krishnamurthy PV; Shankar VJ; Ashok TP; Nedunchelian K; Mala N; Ahmed SS
    Indian Pediatr; 1990 Sep; 27(9):919-23. PubMed ID: 2286435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal age for vaccinating Nigerian children against measles. I. Neonatal antibody profile and subsequent susceptibility to measles.
    Harry TO; Ogunmekan DA
    Trop Geogr Med; 1981 Dec; 33(4):375-8. PubMed ID: 7342384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles antibody in mothers and infants 0-2 years and response to measles vaccine at the age of 9 and 18 months.
    Techasena W; Sriprasert P; Pattamadilok S; Wongwacharapipoon P
    J Med Assoc Thai; 2007 Jan; 90(1):106-12. PubMed ID: 17621740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroepidemiology of measles in Bombay.
    Mehta NA; Nanavati AN; Jhala HI; Sant MV
    Indian J Med Res; 1972 May; 60(5):661-9. PubMed ID: 4663234
    [No Abstract]   [Full Text] [Related]  

  • 14. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison between the plaque reduction neutralization test and the hemagglutination inhibition test in determination of human anti-measles antibodies].
    Kong J; Guo SH; Ze WY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Apr; 17(2):105-7. PubMed ID: 8758407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles antibody levels in 3 to 9 months old infants.
    Dongre ST; Biranjan JR; Jalgaonkar SV; Polakhare JK
    Indian Pediatr; 1989 Aug; 26(8):775-9. PubMed ID: 2620978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
    Liu BY; Feng ZX; Xu AQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):263-5. PubMed ID: 8706090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.
    Martins C; Bale C; Garly ML; Rodrigues A; Lisse IM; Andersen A; Eriksson M; Benn CS; Whittle H; Aaby P
    Vaccine; 2009 Aug; 27(38):5220-5. PubMed ID: 19596409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.